Patients with DM and receiving oGLD monotherapy and insulin users had significantly higher age (p <0.001), while those who were insulin users and those without receiving any GLD were more likely to be female (p <0.001) (Table 1). The gene discussed is INS; the disease is diabetes mellitus.